Cargando…
In Silico Repurposed Drugs against Monkeypox Virus
Monkeypox is an emerging epidemic of concern. The disease is caused by the monkeypox virus and an increasing global incidence with a 2022 outbreak that has spread to Europe amid the COVID-19 pandemic. The new outbreak is associated with novel, previously undiscovered mutations and variants. Currentl...
Autores principales: | Lam, Hilbert Yuen In, Guan, Jia Sheng, Mu, Yuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415168/ https://www.ncbi.nlm.nih.gov/pubmed/36014515 http://dx.doi.org/10.3390/molecules27165277 |
Ejemplares similares
-
Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach
por: Sahu, Anshuman, et al.
Publicado: (2023) -
Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022) -
Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation
por: Gulati, Pallavi, et al.
Publicado: (2023) -
A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus
por: Alandijany, Thamir A., et al.
Publicado: (2023) -
Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023)